Cytori CEO Calhoun on Stem Cell Therapies, Contract

Sept. 28 (Bloomberg) -- Christopher Calhoun, chief executive officer of Cytori Therapeutics Inc., talks about the company's $4.7 million contract with the U.S. government to develop a stem cell therapy to treat burns caused by thermal or radioactive bombs. The contract may be worth $106 million over five years if certain milestones are met. Calhoun speaks with Erik Schatzker and Sara Eisen on Bloomberg Television's "Market Makers." (Source: Bloomberg)

The LM Perpetual is MB&F's Most Ambitious Watch Yet
34:44 - Independent watch brand MB&F's latest creation is the LM Perpetual, a complicated perpetual calendar that showcases the unique mechanism powering the watch. Bloomberg Pursuit's Stephen Pulvirent has been finding out more.
  • Why the Bank of Japan May Ease More in 2016
  • Does Islamic State Benefit From Downing of Russian Plane?
  • UBS Says Oil Among Best Bets After Commodities Rout